Comparative Pharmacology
Head-to-head clinical analysis: GOLYTELY versus OSMOPREP.
Head-to-head clinical analysis: GOLYTELY versus OSMOPREP.
GOLYTELY vs OSMOPREP
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol 3350 is an osmotic laxative that induces diarrhea by retaining water in the bowel lumen through osmotic activity. Electrolytes (sodium sulfate, potassium chloride, sodium bicarbonate) prevent significant electrolyte absorption or loss.
Osmotic laxative. Sodium phosphate draws water into the intestinal lumen via osmotic gradient, increasing intraluminal pressure and stimulating peristalsis.
240 mL (oral) every 10 minutes until 4 L consumed or rectal effluent is clear; typically 4 L total over 3-4 hours.
3 tablets orally in the evening before colonoscopy, followed by 3 tablets the next morning, each dose with at least 1.5 L of clear liquids; maximum 6 tablets total.
None Documented
None Documented
Not applicable (PEG 3350 is not significantly absorbed; effective half-life in GI tract is approximately 2-4 hours for colonic clearance).
The terminal elimination half-life of the absorbed fraction is approximately 2.7 hours. This short half-life indicates rapid renal clearance of the small amount absorbed; however, the clinical effect (bowel cleansing) is independent of systemic elimination.
Primarily fecal elimination of unabsorbed polyethylene glycol 3350. Minimal systemic absorption (<0.06%), less than 0.06% recovered in urine as intact PEG 3350; electrocytes and sulfate (from sodium sulfate) are renally excreted.
Osmoprep (sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous) is not significantly absorbed systemically; the majority of the administered dose remains in the gastrointestinal tract and is eliminated in the feces. Less than 1% of the dose is absorbed and subsequently excreted unchanged in the urine via renal filtration.
Category C
Category C
Osmotic Laxative
Osmotic Laxative